This three day course will emphasize modern PET/CT Imaging and Molecular Imaging and Therapy (MIT) with targeted imaging and therapy radiotracers. This will include 12 hours of lectures from MIT leaders around the world and 12 hours of dedicated computer workstation time for attendees to personally review over 500 PET/CT studies. This course is designed for radiologists and nuclear medicine physicians, and others ordering or interpreting oncologic PET/CT studies. At the conclusion of this activity, learners will be able to optimally apply and interpret FDG, Dotatate, Prostate Specific Membrane Antigen (PSMA), and Estrogen Receptor (ER) PET/CT and corresponding molecular therapies.
Gary Ulaner, MD, PhD, FACNM
James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy
Hoag Family Cancer Institute
All Healthcare Providers:
*Early rate is good on or before 1/31/2023